KRAS and mucinous adenocarcinoma: Curable disease, treatment setting (neoadjuvant, adjuvant, or metastatic), mucinous adenocarcinoma, T4b stage (tumor grown into or attached to other organs or structures), oligometastatic disease, absence of biologic treatment, M1c (cancer spread to distant parts of the peritoneum), history of smoking, and KRAS mutations are the most important categorical variables.